STAT+: J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
More than three-quarters of the multiple myeloma patients treated with an experimental CAR-T therapy from…
Category: STAT+
STAT+: Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients
Kura Oncology presented early clinical trial results Saturday showing for the first time that its…
STAT+: FTC says the number of pay-to-delay cases remains low, but vows to keep watch
Although more drug makers are settling patent infringement lawsuits, the U.S. Federal Trade Commission found…
STAT+: A longtime health care investor on the wild ride of 2020 and what to expect in 2021
It’s time to talk about biotech and 2021. What will the year ahead look like…
STAT+: Pharmalittle: Cyberattacks and criminal gangs target Covid-19 vaccines; whistleblower raps FDA oversight
And so, another working week will soon draw to a close. Not a moment too…
.jpg)
STAT+: With growing usage and few generics, Medicare spending on inhalers is climbing
Over a recent seven-year period, Medicare Part D spending on inhalers used to control respiratory…
STAT+: Pharmalittle: FDA’s Hahn defends Covid-19 vaccine vetting; U.K. denies cutting corners to approve Pfizer shot
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Steered by a former Uber Health exec, a new startup aims to bridge in-home care and telemedicine
Telemedicine has become a lifeline during the Covid-19 pandemic, but it is not enough help…
STAT+: Covid-19 vaccines will arrive before the data sharing technology that could help track them
Scientists have produced Covid-19 vaccines in record time. But the digital connectivity needed to closely…
STAT+: Genetic reprogramming rejuvenates nerve cells and restores vision in mice
For years now, biologists have been practicing a kind of time travel. You can take…
STAT+: Pharmalittle: U.K. approves Pfizer Covid-19 vaccine; Trump pressures FDA to approve Covid-19 shots
Rise and shine, everyone, another busy day is on the way. In fact, the middle…
STAT+: Ovid’s treatment for a rare, untreatable disease fails in a key trial
Ovid Therapeutics’ experimental drug for a devastating rare disease proved no better than placebo in…
STAT+: Pharmalittle: Serum Institute threatens to sue Covid-19 vaccine trial participant; U.S. agency prepares for Covid-19 vaccine fraud
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Agios drug for rare form of anemia achieves main goal of late-stage clinical trial
Agios Pharmaceuticals said Tuesday that its experimental drug mitapivat increased hemoglobin levels in patients with…
.jpg)
STAT+: Legend Biotech believes it is not a target of Chinese investigation, CEO says
The new CEO of Legend Biotech says the company has seen no indication that it…
STAT+: Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA
WASHINGTON — Ask some key public health officials, and they’ll warn you that next year,…
STAT+: FDA spikes a drug approval program that inadvertently led to price hikes and shortages
After years of mounting criticism, the federal government is planning to end a controversial program…
STAT+: Medicines Patent Pool expands deal for access to key HIV drug to several countries
In a bid to expand access to a key AIDS drug, ViiV Healthcare and the…
STAT+: Pharmalittle: Moderna seeking regulatory clearance for Covid-19 vaccine; charter flights begin for Pfizer vaccine
Good morning, everyone, and nice to see you again after an extended holiday break on…
STAT+: Startup Spotlight: Bullish on its asthma treatment, Kinaset forges ahead in unusual times
Launching a clinical trial for a drug intended to treat severe asthma during a respiratory…
STAT+: ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
On the evening that would jolt the global traffic of cancer treatments, David Kim was…
STAT+: In major bet, Biogen pays $1.5 billion for rights to a once-failed treatment for depression
Biogen, placing a major bet on a once-failed treatment, is paying $1.53 billion for the…
STAT+: House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing
A congressional committee has asked the chief executive officer of Purdue Pharma and some members…
STAT+: Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on the last work…
STAT+: ‘The trend is irreversible’: How Covid-19 could drive a shift toward decentralized trials
Covid-19 started as a disaster for clinical research, halting or delaying 3 of every 4…
STAT+: Alnylam wins FDA approval for first drug to treat rare kidney disease
Alnylam Pharmaceuticals Inc. scored its third approval from the US Food and Drug Administration in…
STAT+: Which pricey drugs will Trump’s international pricing policy target?
A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
STAT+: Pharmalittle: EU plots a crackdown on delay of generic drugs; Russia says its Covid-19 vaccine is 95% effective
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: A new startup wants to use natural killer cells to fight cancer
On a blustery day last December, five biotech entrepreneurs and scientists walked past the snow-draped…
STAT+: Pharmalittle: AstraZeneca says its vaccine cuts Covid-19 risk by 70%; U.S. shots will ‘hopefully’ start within three weeks
Good morning. I’m Elizabeth Cooney, filling in for Ed Silverman today as he prepares to…
STAT+: Merck to pay $425M for biotech to get Covid-19 drug, but says manufacturing will be a challenge
The drug giant Merck said Monday it would purchase Rockville, Md.-based OncoImmune for $425 million…
STAT+: Raging at the pandemic, a VC raises $800M for a company that aims to transform biotech manufacturing
In March, as waves of Covid-19 cases began surging across the U.S., biotech venture capitalist…
STAT+: NIH fails to disclose enough details about drug licensing, watchdog report finds
Amid increasing debate over the cost of prescription drugs, a federal watchdog agency found the…
STAT+: Trump’s making last-minute drug pricing reforms — and surprisingly, Democrats want Biden to keep the biggest one
WASHINGTON — President-elect Joe Biden has already pledged to dismantle a number of Trump-era policies…
STAT+: New research underscores the link between multiple sclerosis and the gut microbiome
Researchers have uncovered more evidence that there is a link between a person’s gut microbiome,…
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share…
STAT+: Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Cancer vaccine cocktail boosts immune response after melanoma surgery, research shows
Immunotherapies have transformed cancer care by enlisting the body’s own immune system to fight tumors…
STAT+: To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose
As Purdue Pharma faced serious challenges to OxyContin sales, the company was advised to consider…
STAT+: A leading AI researcher calls for standards to ensure equity and fairness
A top researcher at the Massachusetts Institute of Technology on Thursday said that artificial intelligence…
STAT+: Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs
Top of the morning to you and a fine one, it is. Blue skies and…
STAT+: House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies
Seeking to boost competition in the pharmaceutical industry, the House passed a bill that would…
STAT+: How Amazon Pharmacy could ramp up pressure on the prescription drug industry
The launch of Amazon Pharmacy on Tuesday sent shockwaves through the pharmacy pipeline, with industry…
STAT+: Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
STAT+: Biden team ramps up outreach to public health groups
WASHINGTON — Nearly all of the nation’s leading public health organizations have already heard directly…
STAT+: FDA vows to disclose data used to support emergency drug authorizations
In response to blistering criticism, the Food and Drug Administration committed to publicly disclosing reviews…
STAT+: Pharmalittle: Pfizer launches pilot program to deliver Covid-19 vaccine; Amazon announces new online pharmacy offering
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT+: Brainstorm’s cell therapy for ALS fails study, but company sees signs of efficacy — and may push for approval
Brainstorm Cell Therapeutics reported disappointing results Tuesday from a late-stage clinical trial involving its experimental…
STAT+: Amazon, expanding its growing health empire, launches Amazon Pharmacy
Amazon added new territory to its burgeoning health care empire on Tuesday, launching Amazon Pharmacy,…